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Abstract
Introduction
Developments in information technology offer opportunities to enhance medication safety in
primary care. We evaluated the implementation and adoption of a complex pharmacist-led
intervention involving the use of an electronic audit and feedback surveillance dashboard to
identify patients potentially at risk of hazardous prescribing or monitoring of medicines in
general practices. The intervention aimed to create a rapid learning health system for medi-
cation safety in primary care. This study aimed to explore how the intervention was imple-
mented, adopted and embedded into practice using a qualitative process evaluation.
Methods
Twenty two participants were purposively recruited from eighteen out of forty-three general
practices receiving the intervention as well as clinical commissioning group staff across Sal-
ford UK, which reflected the range of contexts in which the intervention was implemented.
Interviews explored how pharmacists and GP staff implemented the intervention and how
this affected care practice. Data analysis was thematic with emerging themes developed
into coding frameworks based on Normalisation Process Theory (NPT).
Results
Engagement with the dashboard involved a process of sense-making in which pharmacists
considered it added value to their work. The intervention helped to build respect, improve
trust and develop relationships between pharmacists and GPs. Collaboration and
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Data Availability Statement: This is a qualitative
study confined to a single locality (Salford UK). Our
ethics approval was granted based on the
anonymity of the individuals consenting to
participate. Participants were drawn from a small
group of health care professionals in specific roles,
particularly the pharmacists delivering the
intervention. Providing additional information
beyond the carefully selected anonymised
quotations that support the findings in the
communication between pharmacists and clinicians was primarily initiated by pharmacists
and was important for establishing the intervention. The intervention operated as a rapid
learning health system as it allowed for the evidence in the dashboard to be translated into
changes in work practices and into transformations in care.
Conclusions
Our study highlighted the importance of the combined use of information technology and the
role of pharmacists working in general practice settings. Medicine optimisation activities in
primary care may be enhanced by the implementation of a pharmacist-led electronic audit
and feedback system. This intervention established a rapid learning health system that
swiftly translated data from electronic health records into changes in practice to improve
patient care. Using NPT provided valuable insights into the ways in which developing rela-
tionships, collaborations and communication between health professionals could lead to the
implementation, adoption and sustainability of the intervention.
Introduction
Prescribing medication is one of the most common processes in primary healthcare, with over
one billion prescription items issued each year in England alone.[1, 2] Unlike much of Europe
and the USA the first contact for patients in the UK is almost always with a GP rather than a
specialist and therefore much acute and repeat prescribing takes place in primary care. In the
UK general practices are self-contained organisations of GPs which might employ nurses and
pharmacists to help them with prescribing and/or manage medicines optimisation. Medicines
optimisation has been defined as ’a person-centred approach to safe and effective medicines
use, to ensure people obtain the best possible outcomes from their medicines’.[3] Within pri-
mary care it has been shown that errors can occur in the prescribing of medicines or where
patients in receipt of prescribed medicines are not routinely monitored through routine blood
tests.[4, 5] In a retrospective study of prescribing in 15 English general practices over one year,
the prevalence of monitoring or prescribing errors in over 6000 unique prescription items was
4.9%, with 18.7% of patients receiving at least one prescribing or monitoring error.[4] Between
5% and 13% of hospital admissions are due to adverse drug events (ADE) following patients
receiving prescription medication in primary care.[6, 7] Similarly in primary care in the USA
it has been found that 25% of patients had an ADE after receipt of at least one prescription in a
four week period, with 13% of these deemed serious and 11% preventable. [8] Finding ways to
routinely monitor prescribing safety in order to avert potential harm is therefore key.[4] Pre-
scribing safety indicators describe prescribing and monitoring events that may place patients
at risk of harm: a recent study using electronic primary care health record data from across the
UK reported that 5.26% (95% CI 5.21% to 5.30%) of patients were affected by at least one pre-
scribing safety indicator and 11.8% (11.6% to 11.9%) were affected by at least one monitoring
indicator.[9] In the English city of Salford, data from general practices revealed similar rates of
5.45% for prescribing and 7.65% for monitoring indicators, respectively.[10]
The increasing use of information technology (IT) in healthcare offers new opportunities to
enhance medication safety.[11, 12] However, implementation of IT-based interventions has
previously encountered problems through limited user acceptance, issues with ownership and
problems embedding the intervention into existing work practices.[13–18] In primary care, IT
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systems can interrogate population-based prescription records and thus provide surveil-
lance for hazardous prescribing in the community.[10] A recent systematic review of 10
randomised controlled trials of IT interventions to improve medication safety in primary
care found that half the studies reported a reduction of medication errors.[19] An example
is the pharmacist-led information technology intervention for medication errors (PINCER),
which has been shown to be an effective method for reducing a range of clinically important
and commonly made medication errors in primary care.[20] At 6-months follow-up,
patients exposed to the PINCER intervention had significantly fewer prescribing errors
than those in the control group receiving simple feedback on hazardous prescribing. A
nested qualitative evaluation of the same trial identified important factors, such as relation-
ship building between pharmacists and GPs, that could underpin successful implementation
of the intervention in general practice.[21] It was suggested that future research might
explore the opportunities for enhanced integration of pharmacists into the general practice
health care team.[22] The intervention described below, builds upon these recommenda-
tions but additionally utilises a near-real time surveillance dashboard to create a learning
health system to improve medication safety.
The concept of rapid learning health system (LHS) was proposed as a way of gathering new
evidence from routine care and deploying that evidence swiftly into practice using cycles of
continuous learning and improvement.[22, 23] A LHS utilises IT, such as electronic health rec-
ords, for real time learning in daily medical practice and the subsequent transformation of
care.[22–24] An important aspect of rapid learning health systems is the cyclical process from
data to learning to providing feedback to clinicians.[25] By utilising clinical pharmacy support
alongside a real-time surveillance dashboard the present intervention has the potential to cre-
ate a rapid learning health system for medication safety in primary care.
The intervention
The intervention was implemented in general practices across the city of Salford, UK, a large
urban area in the Northwest of England with a population of 270,000 that is part of the Greater
Manchester conurbation. Salford has one hospital, 45 primary care practices, and a shared
electronic health record infrastructure between them. The intervention was a complex phar-
macist-led intervention designed to identify and feedback instances of potentially hazardous
prescribing. Whilst this was based on the PINCER intervention it had two important differ-
ences; the access to a real-time surveillance dashboard for pharmacist and GP staff on a day-
to-day basis and that pharmacists were based in the participating practices.[26] The dashboard
uses a suite of thirteen prescribing and monitoring safety indicators focusing on situations of
potentially hazardous prescribing that could result in patients experiencing harm (S1 Appen-
dix). Pharmacists based in the participating general practices identified patients at potential
risk of hazardous prescribing and drug monitoring using the dashboard and undertook
reviews of their medications, tests and diagnoses using the patient’s electronic medical health
records The intervention allowed for all levels of review from medicines use reviews to full
clinical medication review with or without the patient present depending on the nature of the
hazardous prescribing and the intervention that the pharmacist adopted to best address this.
They then worked with the general practice staff to resolve the risk if present. The pharmacists
received training in the underpinning evidence-base relating to the safety indicators, use of the
dashboard, and root cause analysis informed by the earlier PINCER study.[27] Some pharma-
cists had previously worked in general practice but others had worked previously in hospital
settings. Salford Royal NHS Foundation Trust implemented a Neighbourhood Integrated
Practice Pharmacist (NIPP) service in 2016 in which clinical pharmacists were employed to
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work in general practices to optimise medicines use. A number of these pharmacists were
involved in the intervention.
The Medical Research Council has suggested that evaluations of complex interventions
need to identify the mechanisms associated with how and why the intervention might lead to
outcomes and identify contextual factors.[28, 29] IT interventions to improve health care have
been understood as complex programmes delivered in complex settings involving complex
processes.[30] Process evaluations need to take into account how the technology is imple-
mented in dynamic organisational contexts.[31–33] A recent systematic review of electronic
audit and feedback interventions suggested that insufficient clarity in previous studies meant
the active components of interventions could not be fully understood, and recommended that
future evaluations of systems should utilise theoretical approaches.[34] This study specifically
aimed to explore the ways in which the intervention was implemented, adopted and embedded
into everyday practice (or not) using a qualitative process evaluation consisting of semi-struc-
tured interviews with pharmacists, general practitioners, and other general practice staff.
Methods
Framework: Normalization process theory
Normalization Process Theory (NPT) [35–38] can highlight how an intervention is integrated
and adopted into routine practice. NPT has previously been used to evaluate prescribing safety
interventions in primary care [39–40], and has utility in examining how individuals and
groups understand the intervention through processes of sense-making and how they work to
enable the intervention to happen.[35–38] Interventions become part of everyday practice
only through the work that people, individually or in groups, undertake.[38] NPT is built
upon four constructs: coherence, cognitive participation, collective action and reflexive moni-
toring [35–38] as described in Table 1.
Recruitment to the intervention
The qualitative process evaluation was carried out during the implementation of the interven-
tion in forty-three general practices across Salford Clinical Commissioning Group (CCG),
Table 1. Normalization Process Theory (NPT) constructs [35–38].
NPT constructs
Coherence Cognitive participation
The ways in which people define the intervention and
how they make sense of it.
The work people do to understand how the intervention
might involve a different set of practices.
The work people do together to understand the
intervention and to integrate it into a healthcare setting.
The individual tasks involved in the intervention and
what people do to attribute worth to that new practice.
How people organise themselves and others through
relational work to implement the new intervention.
Working together to collectively contribute to the new
ways of working that the intervention requires.
How the actions and procedures that will be needed to
sustain the intervention are defined.
Collective action Reflexive monitoring
How the intervention is operationalised and enacted in
practice.
The collective and interactional work that people do with
each other in order to adopt the new intervention into
practice.
The knowledge work to build confidence in the new
practice, divisions of labour and allocation of work
including the tasks people do and how those tasks are
related to their existing skill sets.
How other individuals and groups evaluate the
intervention and look to sustain it.
The work that participants do individually and
collectively to evaluate and determine how effective the
intervention is for them and for others.
The impact of the new practices upon their own work.
This may include attempts to modify the intervention.
https://doi.org/10.1371/journal.pone.0205419.t001
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which serves a population of approximately 270,000 residents. Each individual general practice
in Salford CCG was eligible to participate in the intervention. Practice managers initially gave
written consent to receive the intervention and participate in the evaluation.
Recruitment of participants
The study design was a qualitative process evaluation using semi-structured interviews. The
sampling frame was determined by the scope of the intervention and therefore included GP
staff and pharmacists in practices where the intervention was introduced, and CCG staff who
had responsibilities for medicines optimisation and quality improvement in the region.
Twenty–eight members of the sampling frame (nine GPs, twelve pharmacists, seven other GP
staff) at twenty-three general practices out of the forty-three practices receiving the interven-
tion were directly contacted by MJ via telephone or email and invited to take part in an inter-
view. These practices were purposefully sampled to reflect a range of different contexts and
settings which may have had an impact upon how the intervention was implemented and
adopted. These included, variations in practice size, social deprivation and clinical systems
used (EMIS Web; InPractice systems VISION). Twenty-two participants were recruited from
eighteen of these practices. Additionally five CCG managers were approached. Participant
roles are detailed in Table 2.
Ethics approval and consent to participate
Ethical approval for the study was granted by the North West–Greater Manchester East NHS
Research Ethics Committee (reference15/NW/0792). All interview participants gave written
informed consent to take part in the study, and for the interviews to be audio recorded and
transcribed verbatim.
Data collection
The interview schedules (S2 Appendix) were informed by NPT [35–38] to examine how par-
ticipants made sense of the intervention, the interactional work involved in its adoption and
implementation, the ways the intervention was used in practice and how it was appraised. Fol-
low up interviews were conducted with four participants opportunistically sampled from those
who were working in practices that were early implementers of the intervention and sampled
to reflect the range of different professionals using the dashboard. The follow-up interviews
were designed to explore changes in the intervention over time. Interviews were conducted by
MJ at the general practice where the participant was working, on university premises, at the
local NHS hospital trust or CCG offices. The first interviews were conducted between March
and December 2016 as the intervention was implemented in different practices across Salford.
Follow-up interviews were conducted between July and September 2016. Participants were
reimbursed with £20 shopping vouchers per interview.
Data analysis
MJ led the data analysis, which was thematic and conducted concurrently with data collection
[41]. After the first six interviews were conducted the transcripts were read independently and
discussed by MJ, RNK and DLP to uncover emerging themes [41]. These formed an initial the-
matic coding framework, and were applied to the transcripts by MJ using QSR NVivo 11 in
order to manage the data. As data collection continued, further transcripts were added to the
dataset and coded alongside the initial interviews and the thematic coding framework devel-
oped and changed. Data collection continued until, it was agreed in discussions between MJ,
Developing a learning health system to improve medication safety in primary care
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DLP and RNK that no new codes or themes were emerging from the interviews and thus data
saturation had been reached. The coding and emerging themes were discussed by MJ, DLP
and RNK and consensus reached. Consistent with NPT these themes were then grouped,
mapped and interpreted alongside the four NPT constructs [42].
Results
Twenty-one interviews were undertaken with twenty–two participants: three CCG managers,
twelve pharmacists (one of whom was qualified to prescribe medicines independently), four
GPs, one practice nurse, one practice administrator and one practice manager to explore a
range of different views of those exposed to the intervention (see Table 2) between April and
December 2016. Four individual staff from these eighteen practices declined to take part
mainly due to workload and time issues. Additionally two CCG managers declined to take
part.
Table 2. Details of study participants.
Participant Practice Role Role within Intervention
CCG
Manager1
n/a CCG Quality and Improvement Manager Aligning intervention with other quality and improvement initiatives
CCG
Manager2
n/a CCG Quality and Improvement Manager Aligning intervention with other quality and improvement initiatives
CCG Pharm A, B, C CCG based pharmacist Overview of medicines optimisation activities across the Clinical
commissioning group
Implementing intervention in three different practices
GP1 D GP Prescribing lead for practice
GP2 E GP Prescribing lead for practice
GPAdmin1 E GP Admin- Booking clerk Administered recall system for patients requiring monitoring
PM (Joint interview with
PN)
G GP- Practice manager Overview of medicines safety and quality and improvement initiatives
for the practice
PN (Joint interview with
PM)
G GP—Practice Nurse Involved in quality and improvement initiatives for the practice
GP6 H GP No direct involvement with dashboard—communicated with
pharmacist
GP7 H GP No direct involvement with dashboard—communicated with
pharmacist
P1 F Practice based pharmacist Employed by practice—intervention only part of role
P2 G Practice based pharmacist Employed by practice—intervention only part of role
P3 E Practice based pharmacist Employed for the specifically to implement the intervention
P4 D, H Practice based pharmacist Employed by practice intervention only part of role
P5 B, E, I Practice based pharmacist Employed for the specifically to implement the intervention
P6 J, K, L, M, N,
O
Practice based pharmacist Neighbourhood Integrated Practice Pharmacist
P7 H Practice based pharmacist with a prescribing
qualification
Employed by practice—intervention only part of role
P8 G Practice based pharmacist Employed by practice—intervention only part of role
P9 J, K, L, M, N, Practice based pharmacist Neighbourhood Integrated Practice Pharmacist
P10 Q, R, S, T Practice based pharmacist Neighbourhood Integrated Practice Pharmacist
P11 N, O Practice based pharmacist Neighbourhood Integrated Practice Pharmacist
P12 P Practice based pharmacist Employed by practice—intervention only part of role
Key: CCG–Clinical Commissioning Group; GP–General Practitioner; P–Pharmacist; PM–Practice Manager; PN–Practice Nurse
https://doi.org/10.1371/journal.pone.0205419.t002
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Interviews lasted between 14 and 62 minutes. Each participant was interviewed once indi-
vidually, with the exception of a practice nurse and practice manager who took part in a joint
interview. Three months later, a further four interviews were conducted with a purposive sam-
ple of the participants who had taken part in early interviews (three pharmacists and one GP)
to explore whether any changes had occurred. The main findings are mapped onto the four
NPT constructs as summarised in Table 3.
Coherence: Making sense of, and setting up, the intervention in the context
of pharmacist and GP working practices
Perceptions of ease of use. Pharmacists, GP staff and CCG managers felt the intervention
to be valuable: it provided quick and easy access to actionable data and streamlined the way
they worked. The dashboard potentially saved time since it provided near real-time informa-
tion on hazardous prescribing. Compared to similar initiatives it did not require laborious
audits to be run in the GP clinical system by practice staff:
"I think the main benefit is that it’s just how quick and easy it is to access these patients. [. . .]
Running the searches on [the GP clinical system] I think is a nightmare. [. . .] For me I literally go
in, in the morning [. . .] and I have all my patients straightaway” (Practice pharmacist -P11)
And similarly acknowledged by other practice pharmacists;
“. . .it’s just quick and easy isn’t it? You can turn up at a surgery, log on the dashboard, ‘cause
you’ll have access to that surgery, and within an hour you could have made several safety
interventions, from just turning up at a random doctor’s surgery, [. . .]you can just walk in,
and you could have made quite an impact.” (Practice Pharmacist -P3)
Pharmacists considered the dashboard added value to their work. Engagement with the
dashboard enabled pharmacists to review a patient’s medical records and undertake actions to
ensure they were no longer at risk. This involved a process of sense-making in which the
Table 3. Normalisation process theory constructs mapped to the identified themes.
COHERENCE. Sense-making work: How pharmacists and GP staff
understood and attributed worth to the intervention.
COGNITIVE PARTICIPATION. Relational work that people did to set up and
establish the intervention; enrolment, engagement and buy-in
The dashboard was perceived as easy to use
Pharmacists considered the dashboard added value to their work
The intervention was perceived to be embedded in the context of wider
medicines safety activities.
Pharmacists were largely responsible for integrating it into the GP practice.
Pharmacists considered that they overcame resistance to the intervention
through sense-making work with other practice staff.
Collaborations established the intervention with pharmacists leading this by
demonstrating the dashboard to others within the practice.
There was varied access and engagement from different stakeholders
Pharmacists felt that trust and confidence in the dashboard and in the work of the
pharmacists highlighting hazardous prescribing and initiating changes to patient’s
medication was important in establishing the intervention.
COLLECTIVE ACTION. The work undertaken to sustain and
operationalise the intervention: interactions, relationships and
collaborations.
REFLEXIVE MONITORING. Appraising and monitoring: how pharmacists and
clinicians reflected upon and appraised the intervention
Communication and collaboration was seen as important
Collaborations between pharmacists and prescribers were based upon
agreement and planning.
The dashboard was perceived to help to build relationships.
Pharmacists met together and gave feedback to the research team which led to
developments in the dashboard.
The intervention was seen as a tool that could lead to changes in work practices
Pharmacists broadened their actions from attending to high risk prescribing cases to
undertaking full medicine reviews with patients.
Education and development important to the intervention
The dashboard was seen as presenting opportunities for further medicines safety
activities.
https://doi.org/10.1371/journal.pone.0205419.t003
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pharmacists considered the dashboard added value to their work, which in turn motivated
them to continue to use it:
“At the moment there’s seven [. . .] patients that have fallen off [i.e. no longer highlighted by the
dashboard as at risk] in the time that I’ve been there that I know that I have personally reviewed.
They’re safer now. [. . .] For it to be quantifiable like that, is really nice” (Practice Pharmacist -P9)
Wider medicine safety activities. The intervention was also understood in the context of
wider medicine safety activities. Pharmacists and clinicians were more likely to use the dash-
board if it helped to fulfil the requirements of other incentivised schemes. General practices
were described as busy and under pressure from competing priorities such as the constant
flow of new initiatives.
“. . .from what I understand in GP land, they get . . .every year they get something new thrown
at them, something new, something exciting, something that is basically going to change the
way they get paid.” (Practice Pharmacist -P2)
Integrating the intervention into practices. Pharmacists worked with GPs and other prac-
tice staff to build an understanding of the intervention and what it could achieve. This often
involved the pharmacists demonstrating the dashboard to clinicians and other staff members, as
individuals or small groups, in order to integrate the intervention into the practices.
“So, showed them [the GP] the dashboard, where I had got the information from, because it
was a good way to get his buy-in into the dashboard, to say, oh, look what this can do, look
what it has found. (Practice Pharmacist -P1)
Resistance to the intervention. There was some resistance from clinicians and GP staff,
and a need to build awareness that the intervention could "save (medication safety) problems in
the future" (Practice Pharmacist -P11). Similarly one pharmacist commented that potential
resistance from GPs was related to a perception that the intervention would involve extra
work, and this first had to be overcome in order for any benefits to be realised.
Cognitive participation: Enrolment and engagement to establish the
intervention
Collaboration established the intervention. Collaboration between stakeholders was
important for establishing the intervention. Giving clinicians access to the dashboard and
showing them the tool was perceived as important to get practice staff “on board”.
“So I got involved in a lot of the setup in the practices that I’ll be working in and also showing
them [practice staff] the dummy [version of the dashboard], and then getting them on board
with it. And the initial feedback we got was all very positive. A lot of the GPs are on board.
The practice manager is completely on board and excited for it. And [. . .] most of them have
access now as well.” (Practice Pharmacist—P9)
Clinicians provided a way of linking the work of the pharmacist to the wider prescribing
activities in the practice. Pharmacists spoke of needing “a clinician to go to regularly” (Practice
Pharmacist -P2) partly because prescribing changes could only be carried out by a clinician.
Varied access and engagement from different stakeholders. The intervention was per-
ceived to be owned by the pharmacists, as pharmacist P5 reflected:
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"I don’t know if any of them [GPs] are looking at the dashboard themselves. I think the dash-
board is seen as my thing. [. . .] We’ve got them set up with log-ins but I think it could be that
they don’t really know how to use it” (Practice Pharmacist -P5)
A lack of involvement from clinicians was legitimised by suggestions that pharmacists were
experts in medicines with the appropriate skill-sets, and consequently the ideal people to use
the system. It was assumed that pharmacists were much more likely to engage with the system
than clinicians because "they know what they’re looking for and what they’ve already actioned
and what still needs actioning," (Practice Manager -PM).
Trust and confidence. The intervention helped to build respect, improve trust and
develop relationships between pharmacists and GPs. Pharmacists saw the dashboard compo-
nent as offering opportunities to demonstrate their skills and to further develop their role
working within general practice settings. In setting up the intervention it was important that
clinicians had trust and confidence in both the dashboard and the work of the pharmacist.
Such trust and confidence could be achieved as one pharmacist reflected by them "proving
[their] worth" (Practice Pharmacist -P1) through their work in helping to resolve hazardous
prescribing cases and making changes made to patient’s medication. This added value to the
role of a practice pharmacist allowing the pharmacists to develop their professional role in gen-
eral practice. Trust and confidence in the intervention was also achieved in that the feedback
provided by the dashboard was seen to be depersonalised:
“Yeah, it does [improve things in practice] and having this tool depersonalises [feedback],
because it is . . .this system has picked up that you have prescribed this. It’s not . . .you know,
you’ve done this and I don’t think it’s safe . . .it’s the system has picked this up, so it depersona-
lises everything [. . .]so it’s a good way of getting feedback without making it personal.” (GP-1)
Collective action: Work undertaken to adopt and sustain the intervention
including communication, collaborations and divisions of labour
Communication and collaboration. Communication and collaboration were seen as
important for the intervention and for embedding the intervention into routine practice.
The communication of messages regarding patients highlighted by the dashboard as being
at risk of potentially hazardous prescribing practice was primarily initiated and led by the
pharmacists. This was important work in order to establish how the intervention was
going to be adopted and operationalised in the practices. Pharmacists adopted different
ways of communication with clinicians, in order to engage them with the intervention.
Since many of the pharmacists had worked in hospital settings previously this involved
contrasting their previous ways of working to the different context of primary care, as well
as building an understanding of the complexities of primary care where group meetings
were perceived as difficult:
"It’s difficult, [. . .] when’s the best time to approach doctors to discuss things, [. . .] when the
surgery is not on, they’re on home visits or they’re in meetings, it’s quite a different way of
working. So that’s probably one barrier [. . .], so it’d be difficult probably to get everybody
together unless you went to the practice meeting on another day. “(Practice Pharmacist -P3)
Most pharmacists relied upon clinicians to make changes to patients’ medication. One
CCG manager, who also worked as a pharmacist, talked of providing clinicians with "simple
messages" if needed and described communication as only driven from necessity.
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“that’s how I’ve been using it [. . .], not bothering the GP too much if they don’t need to be,
[. . .] just simple messages and where patients do need acting on, just passing the NHS number
to the GP and getting that acted upon.”(CCG Pharmacist–CCG Pharm)
Agreement and planning. The collaboration between pharmacists and clinicians in deliv-
ering the intervention was characterised by agreement and planning. Pharmacists discussed
how they worked with GPs "to have agreed an action plan" (Practice Pharmacist -P10). The
pharmacist worked through lists of patients potentially affected by hazardous prescribing but
“action plans” were sent to the relevant clinician. There was therefore some division of labour
happening; pharmacists undertook specific tasks in highlighting patients at risk and suggesting
a suitable plan of action but then these would often be dealt with by clinicians who “would
decide whether to contact the patient, whether to action it or not” (GP1). This role allocation did
have the benefit of giving a sense of value to the intervention. Pharmacists valued the dash-
board in that it was perceived to potentially "lead on to making general practitioners confident
in what pharmacists can do within general practice" (Practice Pharmacist -P10). GPs valued the
additional presence of the pharmacist since it was seen to ensure “. . .things don’t get missed. . .”
(GP7). And as this pharmacist reflected;
“Well that’s the benefit of having it pharmacist led, isn’t it that you know somebody is going to
follow it up and make sure it’s done and keep checking and keep going back and, you know.
Sometimes you give GPs work and they’re just so overloaded that it’s just another thing for
them to be looking at and to be doing . . .” (Practice Pharmacist -P12)
Building relationships. It was also seen as important that the pharmacist developed and
built relationships with practices in order to make the intervention more successful. Relation-
ships between the pharmacist and others were perceived to be built through the use of the
dashboard;
“So, I am using it as an exercise, really, in way of building a relationship with the GPs as well
and for them to see what the SMASH dashboard can do for them. So, I know, potentially, not
everyone is using . . .taking that approach, but I just think it, one, gets SMASH, the dashboard
some PR and is also, yeah, helping me to build some relationships.”(Practice Pharmacist -P10)
Reflexive monitoring: How pharmacists and clinicians reflected upon and
appraised the intervention and the potential for sustaining long-term
system change
Developments in the dashboard. The pharmacists met regularly in a process of sharing
good practice and developing different approaches to working with the dashboard and within
their practices. One such meeting led to a change to the dashboard in the development of a
‘note feature’ that allowed users to give reasons for the actions that had been taken in response
to managing patients that had been highlighted as at risk of hazardous prescribing.
“The fact that now you’ve added the notes system, so I can flag up if we have reviewed some-
body, just to avoid duplication, works good.” (Practice Pharmacist -P6)
Changes in work practices. The intervention was seen as a tool that could develop learn-
ing and lead to changes in work practices and the quality and safety of patient care, for instance
in making changes in the way recall letters for blood test monitoring were conducted.
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“One of the indicators is the Amiodarone and people coming in for six monthly bloods, so I’d
worked with her to put. . . a recall and it’s just to put it on the system and then she checks the
recalls on a monthly basis, [. . .] so she can put it on so that every six months they will come up
in this recall search [. . .] then we got everybody on Amiodarone in general and then she put a
recall on for me for all those people so that nobody ever will breach that indicator again”.
(Practice Pharmacist -P3)
Pharmacist broadening their actions. The role of the pharmacist within the intervention
was to engage in supporting these activities within the practices but in some practices this was
seen as opportunity to translate the evidence provided by the dashboard into transformations
in care by conducting a more comprehensive medication review for patients:
“We’ve actually broadened the remit a little bit, because [. . .]when you have a patient with
one thing [. . .] something that’s identified on the dashboard, there often may be other things,
and our view is holistic care. [. . .]When we look at those patients, we’re obviously looking at
the indicator that flags, but also making sure we look at the wider patient as well.” (Practice
Pharmacist -P6).
Education and development. Several respondents discussed education for individual cli-
nicians, and it was acknowledged that working on high risk prescribing needed to lead to edu-
cation in order to maintain the quality of prescribing. GPs wanted to be “told if we are
prescribing unsafely” (GP1), and would use the dashboard for their “own education” (GP1).
Pharmacists spoke of the need for education and awareness as part of “a personal development
as well” (P4) and for the need for clinicians to “take more of an ownership” (Practice Pharmacist
-P3) in order to bring about change and to “sustain the difference” (Practice Pharmacist -P2).
Education of clinicians was often initiated by pharmacists and involved changes in the interac-
tions between pharmacists and clinicians, in terms of the ways they communicated messages,
and feedback to prescribers from pharmacists that could result in embedding the intervention
into routine practice and in learning to avoid situations of hazardous prescribing when man-
aging other patients.
Future medicines safety activities. The intervention was also seen as presenting opportu-
nities for the further quality and medicines safety programmes in the future. One CCG man-
ager reflected that;
“I think it’ll give us a useful tool to be able to perhaps design our programmes of work, and
also thinking about if we’re going to run any quality programmes in the future, it will hope-
fully help us to design what we’re working on because it will give us that information, give us
that baseline that we need so often.” (CCG1)
Using NPT provided therefore valuable insights into the ways in which developing relation-
ships, collaborations and communication between health professionals could lead to the
implementation, adoption and sustainability of the intervention. The results are summarised
in relationship to the NPT constructs in Table 3. This highlights the main themes under each
construct.
Discussion
This study explored the ways in which a complex, pharmacist-led intervention, using near
real-time electronic audit and feedback, was implemented, adopted, and embedded into every-
day practice creating a learning health system to improve medication safety in primary care.
Developing a learning health system to improve medication safety in primary care
PLOS ONE | https://doi.org/10.1371/journal.pone.0205419 October 26, 2018 11 / 16
One of the key elements of a rapid learning health system is for clinicians to have access to
data and searchable health records at a local level.[23, 43] The intervention allowed for a rapid
learning health system to evolve through the connection of the real time data in the dashboard
to changes in patient’s medication. In this the role of the practice based pharmacist was pivotal.
Good collaborative relationships between the pharmacists and other health professionals was
important in making sense of the intervention, engaging and implementing it and sustaining
it in everyday practice. In a systematic review by Lainer et al IT interventions for were seen as
successful for improving medication safety in primary care if the intervention involved collab-
oration between pharmacists and clinicians. [19]
The pharmacists engaged with the dashboard more than general practitioners and it was
perceived as being owned by the pharmacists. Studies of earlier interventions to improve pre-
scribing in primary care have reported variations in engagement.[39, 40] and have seen differ-
ences in roles with some health professionals utilising technology and others rejecting it.[44]
In the present study there were positive outcomes from the differences in roles since the inter-
vention allowed pharmacists to demonstrate their professional skills through the use of the sys-
tem and develop the role of clinical pharmacy in general practice. This runs somewhat counter
to examples in previous literature that has seen some primary care IT systems reduce the
autonomy and professional discretion of health professionals.[13, 45] It may well suggest that
when technology does fit with the professional norms and values of a specific group of health
professionals it is more likely to be accepted.
Strengths and limitations
The NPT constructs drew out the multifaceted nature of the intervention which included the
dashboard itself, the negotiation of user roles, the fitting of the intervention into general prac-
tice, the wider considerations of the CCG and the pharmacist role. The collective action con-
struct was able to reveal how the dashboard meant different things to different people:
pharmacists using it to feedback instances of high risk prescribing, and GPs using it for their
own education. This fits with an extended version of NPT that focuses upon the complexity of
contexts, the changes in roles and plasticity of the intervention. [46] Using NPT was particu-
larly useful in unpicking what McEvoy et al., have described as the “implementation journey”
where the gradual processes of the intervention towards its adoption in everyday practice is
understood.[47] An important limitation to this study was that the evaluation team also devel-
oped the intervention. Whilst this allowed for some changes to be made to the intervention it
potentially had implications for the ways in which we assumed the dashboard would be utilised
in practice. This may have an impact upon the transferability of these findings to other set-
tings. Furthermore transferability may be limited by the specific nature of the intervention set-
ting and particularly the roles of practice pharmacists as this was an innovative pharmacist-led
intervention. A further limitation is the limited number of follow-up interviews. As described
above this was for pragmatic reasons based upon the timelines of the evaluation which did not
facilitate further interviews to be undertaken. It would therefore be beneficial for future
research to evaluate the roll-out of the intervention in wider settings. As a purely qualitative
study we could not evaluate the impact of the intervention. The research team are, however
collecting quantitative data and this will be reported in the future.
Implications for improving medication safety as a learning health system
Audit and feedback interventions using dashboards and prescribing safety indicators have a
utility in primary care medication safety and could be further implemented across primary
care. A LHS infrastructure that allows for real-time electronic audit and feedback data to be
Developing a learning health system to improve medication safety in primary care
PLOS ONE | https://doi.org/10.1371/journal.pone.0205419 October 26, 2018 12 / 16
available to clinicians at the point of care has the potential to translate evidence swiftly into
practice.[22, 23, 48] Our findings demonstrate that such a rapid learning health system can
help connect data to changes in medication safety particularly through the role of pharmacists.
Such interventions thus, as Friedman has suggested,[25] lead to continuous cycles of improve-
ment since the real time data in the dashboard is continually updated. In this way, prescribing
behaviours and patterns can be reflected upon and changed; new prescribing will be changed
in the dashboard and new learning facilitated. This closed loop enables users to see the results
of their own actions reflected in the dashboard and thus provide positive feedback. Central to
the intervention was the connection between the dashboard and the clinical pharmacist and
the collaborative processes involved in its use and sustainability. The PINCER study [21]
highlighted the importance of the communication between pharmacists and clinicians. The
present study builds upon that by seeing the importance of having the pharmacist embedded
within practices which led to a more active relationship with clinicians based upon agreement
and planning. In the future, similar interventions might take into consideration the impor-
tance of these collaborative processes, how technology use can be translated into practice and
how rapid learning health systems need to fit into existing work practices.[24, 35] The findings
of this study are of particular relevance given the national implementation of clinical pharma-
cists in general practices led by NHS England [49] Internationally it has been suggested that
pharmacists can reduce GP workload and work pressure and deliver a range of interventions
[50–53] Further examination of the professional identity of this role and how it is evolving
within primary care particularly given the WHO Global Challenge to improve medication
safety [54] would be beneficial.
Conclusions
Medicine optimisation activities in primary care may be enhanced by the implementation of a
clinical pharmacist-led electronic audit and feedback system that highlights potentially hazardous
prescribing in general practices. Such an intervention enables a rapid learning health system that
swiftly translates data from electronic health records into changes in practice to improve patient
safety. At the centre of this learning health system, and pivotal to its success and sustainability,
was the role of the clinical pharmacist who provided the link between data and changes in care.
Our study thus highlighted the importance of the combined use of information technology and
the emerging and developing role of clinical pharmacists in general practice The use of NPT as an
analytical framework provided valuable insights into the work of implementation, adoption and
sustainable execution of the intervention, revealing that it was critically dependent upon interac-
tions between the pharmacist, clinicians and other staff members.
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